Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Orbit Discovery and SanegeneBio collaborate to identify targeting peptides for RNAi drugs

Friday, January 06, 2023

Orbit Discovery Limited Orbit a leader in the discovery of therapeutic peptide hits today announced it has entered into a Master Service Agreement with SanegeneBio Inc Sanegene a startup company dedicated to developing novel RNAibased medicines The f...

Simnova and Orna Therapeutics Collaborate to Advance Orna's Next Generation Circular RNA Technology in China

Friday, January 06, 2023

Shanghai Xianbo Biotech Co Ltd also known as Simnova outside of China an affiliate of Simcere Investment Group and a clinicalstage biotechnology company developing proprietary offtheshelf CARNK and BiTEarmed CART cell therapies and Orna Therapeutics...

WuXi Biologics and GSK Enter into License Agreement on Multiple Novel Bi- & Multi-specific T Cell Engagers

Thursday, January 05, 2023

WuXi Biologics a leading global Contract Research Development and Manufacturing Organization CRDMO today announced a license agreement with GSK plc under which GSK will have exclusive licenses for up to four bi multispecific TCE antibodies developed...

Moderna to Acquire OriCiro Genomics

Thursday, January 05, 2023

Moderna Inc a biotechnology company pioneering messenger RNA mRNA therapeutics and vaccines and OriCiro Genomics KK a pioneer in cellfree DNA synthesis and amplification technologies today announced they have entered into a definitive agreement throu...

Gilead and EVOQ Therapeutics Announce Collaboration to Advance Immunotherapies

Wednesday, January 04, 2023

Gilead Sciences Inc and EVOQ Therapeutics Inc EVOQ today announced a collaboration and licensing agreement to advance EVOQs proprietary technology for the treatment of rheumatoid arthritis RA and lupus EVOQs NanoDisc technology is designed to enable...

AmerisourceBergen completes acquisition of PharmaLex

Wednesday, January 04, 2023

AmerisourceBergen Corporation today announced the completion of its acquisition of PharmaLex Holding GmbH The acquisition of PharmaLex enhances AmerisourceBergens growth strategy by advancing its leadership in specialty services and global platform o...

Mission Bio and Abiosciences Partner to Co-develop Bioinformatics for Clinical Research Applications in China

Thursday, December 29, 2022

Mission Bio the pioneer in highthroughput singlecell DNA and multiomics analysis and Abiosciences the singlecell bioinformatics leader announced a new partnership to codevelop bioinformatics packages for translational and clinical research applicatio...

Opus Genetics Announces Acquisition of the Rights to Two Gene Therapy Product Candidates for Inherited Retinal Diseases

Thursday, December 29, 2022

Opus Genetics a patientfirst clinicalstage gene therapy company developing treatments for inherited retinal diseases today announced it has acquired the rights to two preclinicalstage AAVbased gene therapy product candidates for inherited retinal dis...

Kala Pharmaceuticals Announces FDA Acceptance of IND Application for KPI-012 for the Treatment of PCED

Wednesday, December 28, 2022

Kala Pharmaceuticals Inc a clinicalstage biopharmaceutical company dedicated to the research development and commercialization of innovative therapies for rare diseases of the eye today announced that the US Food and Drug Administration FDA has accep...

Gilead to Acquire All Remaining Rights to Potential First-in-Class Immunotherapy GS-1811 From Jounce Therapeutics

Wednesday, December 28, 2022

Gilead Sciences Inc and Jounce Therapeutics Inc amended their existing license agreement for GS formerly JTX enabling Gilead to buy out remaining contingent payments potentially due under the license agreement executed in August As part of the trans...